
GPT Healthcare IPO
- Issue price
- ₹186
- Listing price
- ₹215
- +15.59%
- Current price
- ₹143.81
- -22.68%
- Subscribed
- 8.52x
- Issue size
- ₹525.14 Cr
- Listed on
- 29 Feb 2024
IPO timeline
- Opens22 FebThu
- Closes26 FebMon
- Allotment27 FebTue
- Refunds28 FebWed
- Demat credit28 FebWed
- Listing29 FebThu
Issue details
- Price band
- ₹177 – ₹186 per share
- Issue size
- ₹525.14 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹10 per share
- Lot size
- 80 shares
- Minimum investment
- ₹14,880
- Listing on
- BSE, NSE
- Exchange code
- GPTHEALTH · 544131
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 80 | ₹14,880 |
| Retail (Max) | 13 | 1,040 | ₹1,93,440 |
| S-HNI (Min) | 14 | 1,120 | ₹2,08,320 |
| B-HNI (Min) | 68 | 5,440 | ₹10,11,840 |
Reservation
- QIB
- 1,41,16,660 shares (50.00% of the Offer)
- NII
- 42,34,999 shares (15.00% of the Offer)
- Retail
- 98,81,664 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on MUFG Intime India- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 27 Feb 2024
- Refunds initiated
- 28 Feb 2024
- Shares credited to demat
- 28 Feb 2024
- Listing
- 29 Feb 2024
Grey market premium (GMP)
- Current GMP
- ₹15
- +8.00%
- Estimated listing price
- ₹201
- Issue price ₹186
- Highest
- ₹15
- 23 Feb
- Lowest
- ₹0
- 22 Feb
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 28 Feb 2024 | ₹15 | +8.00% | ₹201 |
| 27 Feb 2024 | ₹15 | +8.00% | ₹201 |
| 26 Feb 2024 | ₹10 | +5.00% | ₹196 |
| 24 Feb 2024 | ₹15 | +8.00% | ₹201 |
| 23 Feb 2024 | ₹15 | +8.00% | ₹201 |
| 22 Feb 2024 | ₹0 | 0.00% | ₹186 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB17.3x
- NII (HNI)11.02x
- Retail2.44x
Financials
- P/E Ratio
- 32.49
- EPS (₹)
- 0.00
- RoE
- 23.59%
- RoCE
- 26.09%
- RoNW
- 23.77%
- PAT Margin
- 10.64%
- Debt / Equity
- 0.39
- NAV (₹)
- 20.54
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 332.09 | 326.76 | 323.22 | 317.21 |
| Total Income | 206.70 | 366.73 | 342.40 | 248.86 |
| Profit After Tax | 23.49 | 39.01 | 41.66 | 21.09 |
| NET Worth | 171.43 | 164.14 | 156.96 | 132.68 |
| Reserves and Surplus | 92.75 | 85.46 | 78.28 | 75.96 |
| Total Borrowing | 55.57 | 64.67 | 95.52 | 122.93 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| GPT Healthcare This IPO | ₹525.14 Cr | 32.49 | 23.77% | 10.64% | 8.52x | +15.59% |
| Gandhar Oil Refinery (India) Mainboard · listed 30 Nov 2023 | ₹500.69 Cr | 7.62 | 32.28% | 5.20% | 65.63x | +76.33% |
| Innova Captab Mainboard · listed 29 Dec 2023 | ₹570 Cr | 36.42 | 24.58% | 7.34% | 56.33x | +0.92% |
| Sahajanand Medical Technologies Mainboard · listed 23 Oct 2026 | ₹475.48 Cr | 57.91 | 2.31% | 4.29% | 14.2x | +7.89% |
| Senores Pharmaceuticals Mainboard · listed 30 Dec 2024 | ₹582.11 Cr | 28.21 | 23.60% | 15.25% | 96.96x | +53.45% |
| Corona Remedies Mainboard · listed 15 Dec 2025 | ₹655.37 Cr | 58.26 | 24.65% | 12.49-13.33% | 137.04x | +38.42% |
| Standard Glass Lining Technology Mainboard · listed 13 Jan 2025 | ₹410.05 Cr | 38.5 | 20.74% | 10.92% | 185.48x | +25.71% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How GPT Healthcare plans to use the money raised, as stated in the offer document.
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company from banks and financialinstitutions₹30 Cr
- General corporate purpose₹7.52 Cr
About GPT Healthcare
GPT Healthcare Limited was incorporated as Jibansatya Printing House Private Limited at Kolkata on 17 August 1989. It runs a chain of mid-sized full service hospitals under the ILS Hospitals brand, with a focus on secondary and tertiary care. On 30 September 2023 it operated four multi-specialty hospitals at Dum Dum, Salt Lake and Howrah in West Bengal and at Agartala in Tripura, with a total capacity of 561 beds. It offers services across over 35 specialties and super specialties, and each hospital also has integrated diagnostics and pharmacies. Its main promoter is GPT Sons Private Limited. The IPO was Rs 525.14 crore, with Rs 40.00 crore of fresh issue and Rs 485.14 crore of offer for sale by investor Banyan Tree. Rs 30.00 crore was planned for repaying borrowings.
Strengths
- Total income rose from Rs 248.86 crore in FY2021 to Rs 366.73 crore in FY2023.
- The source puts the PAT margin at 10.64% and return on net worth at 23.77%.
- Total borrowing fell from Rs 122.93 crore on 31 March 2021 to Rs 55.57 crore on 30 September 2023.
- The promoters did not sell shares, and it runs 4 hospitals with 561 beds.
- Profit after tax was Rs 23.49 crore in the six months to 30 September 2023.
Risks
- Rs 485.14 crore of the Rs 525.14 crore issue was offer for sale, so only Rs 40.00 crore reached the company.
- The pre-issue P/E was 38.1 at the upper band of Rs 186, based on EPS of Rs 4.88.
- Profit after tax fell from Rs 41.66 crore in FY2022 to Rs 39.01 crore in FY2023.
- Three of its 4 hospitals serve most patients, all in eastern India, so local competition matters.
- Promoters and the promoter group held 67.34% before the issue and 65.57% after it.
Promoters and shareholding
GPT Sons Pvt.Ltd, Dwarika Prasad Tantia, Om Tantia and Shree Gopal Tantia
- Promoter holding, pre-issue
- 67.34%
- Promoter holding, post-issue
- 65.57%
Anchor investors
Registrar, lead managers and documents
GPT Healthcare IPO: common questions
1.When does the GPT Healthcare IPO open and close?
The GPT Healthcare IPO opens on 22 Feb 2024 and closes on 26 Feb 2024.
2.What is the price band of the GPT Healthcare IPO?
The price band is ₹177 – ₹186 per share, with a lot size of 80 shares and a minimum investment of ₹14,880.
3.What is the size of the GPT Healthcare IPO?
The issue size is ₹525.14 Cr (Fresh capital cum OFS).
4.What is the GMP of the GPT Healthcare IPO?
The last reported grey market premium is ₹15 per share as of 28 Feb 2024, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the GPT Healthcare IPO allotment?
The basis of allotment is expected on 27 Feb 2024. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.
6.When will the GPT Healthcare IPO list?
The shares listed on 29 Feb 2024 on BSE, NSE.
7.Who is the lead manager of the GPT Healthcare IPO?
The book running lead manager is JM Financial Ltd., and the registrar is MUFG Intime India Private Limited.
8.What will the money raised in the GPT Healthcare IPO be used for?
As stated in the offer document, the proceeds are for: Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company from banks and financialinstitutions; General corporate purpose.
9.How can my company launch an IPO like GPT Healthcare?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393